DLK1 and cancer: The epigenetic dysregulation of the Dlk1-Dio3 miRNA cluster has been documented in various cancer types, such as melanoma [110], leukemia [111], ovarian cancer [112,113], breast cancer [114], bladder cancer [115], metastatic hepatoblastoma [116], and implicated in tumorigenesis.